Novel insights into ChREBP regulation and function

Trends in Endocrinology and Metabolism

Volumn 24, Issue 5, 2013, Pages 257-268

  Filhoulaud, Gaëlle ^a,b,c   Guilmeau, Sandra ^a,b,c   Dentin, Renaud ^a,b,c   Girard, Jean ^a,b,c   Postic, Catherine ^a,b,c  

^a INSTITUT COCHIN   (France)

^b CNRS   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

cell glucotoxicity; Cell proliferation; ChREBP; Glucose sensing; Hepatic steatosis

Indexed keywords

CARBOHYDRATE RESPONSE ELEMENT BINDING PROTEIN; GLUCOSE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

APOPTOSIS; CELL PROLIFERATION; FATTY ACID SYNTHESIS; GENE EXPRESSION REGULATION; GLUCOLIPOTOXICITY; GLUCOSE METABOLISM; GLYCOLYSIS; HUMAN; INSULIN SENSITIVITY; LIPOGENESIS; LIPOTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROCESSING; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ADIPOSE TISSUE; ANIMALS; APOPTOSIS; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CELL PROLIFERATION; GLYCOLYSIS; HUMANS; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; LIPOGENESIS; LIVER; MODELS, BIOLOGICAL; MUSCLE, SKELETAL; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; RESPONSE ELEMENTS;

EID: 84876998618     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2013.01.003     Document Type: Review

References (97)

1. Foufelle F., et al. Glucose stimulation of lipogenic enzyme gene expression in cultured white adipose tissue. A role for glucose 6-phosphate. J. Biol. Chem. 1992, 267:20543-20556.
2. Girard J., et al. Mechanisms by which carbohydrates regulate expression of genes for glycolytic and lipogenic enzymes. Annu. Rev. Nutr. 1997, 17:325-352.
3. Prip-Buus C., et al. Induction of fatty-acid-synthase gene expression by glucose in primary culture of rat hepatocytes. Dependency upon glucokinase activity. Eur. J. Biochem. 1995, 230:309-315.
4. Dentin R., et al. Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression. J. Biol. Chem. 2004, 279:20314-20326.
5. Foretz M., et al. Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:12737-12742.
6. Thompson K., Towle H.C. Localization of the carbohydrate response element of the rat L-type pyruvate kinase gene. J. Biol. Chem. 1991, 266:8679-8882.
7. Shih H., et al. Two CACGTG motifs with proper spacing dictate the carbohydrate regulation of hepatic gene transcription. J. Biol. Chem. 1995, 270:21991-21997.
8. Yamashita H., et al. A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:9116-9121.
9. Stoeckman A.K., et al. Mlx is the functional heteromeric partner of ChREBP in glucose regulation of lipogenic enzyme genes. J. Biol. Chem. 2004, 279:15662-15669.
10. Ishii S., et al. Carbohydrate response element binding protein directly promotes lipogenic enzyme gene transcription. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:15597-15602.
11. Iizuka K., et al. Deficiency of ChREBP reduces lipogenesis as well as glycolysis. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:7281-7286.
12. Proctor G., et al. Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes. Diabetes 2006, 55:2502-2509.
13. da Silva Xavier G., et al. Carbohydrate responsive-element binding protein (ChREBP) binding to fatty acid synthase and L-type pyruvate kinase genes is stimulated by glucose in pancreatic MIN6 β-cells. J. Lipid Res. 2006, 47:2482-2491.
14. Dentin R., et al. Polyunsaturated fatty acids suppress glycolytic and lipogenic genes through the inhibition of ChREBP nuclear protein translocation. J. Clin. Invest. 2005, 115:2843-2854.
15. Ma L., et al. Direct role of ChREBP/Mlx in regulating hepatic glucose-responsive genes. J. Biol. Chem. 2005, 280:12019-12027.
16. Billin A.N., et al. Mlx, a novel Max-like BHLHZip protein that interacts with the Max network of transcription factors. J. Biol. Chem. 1999, 274:36344-36350.
17. Ma L., et al. ChREBP/Mlx is the principal mediator of glucose-induced gene expression in the liver. J. Biol. Chem. 2006, 281:28721-28730.
18. Li M., et al. Glucose-dependent transcriptional regulation by an evolutionarily conserved glucose-sensing module. Diabetes 2006, 55:1179-1189.
19. Fukasawa M., et al. Coordinate regulation/localization of the carbohydrate responsive binding protein (ChREBP) by two nuclear export signal sites: discovery of a new leucine-rich nuclear export signal site. Biochem. Biophys. Res. Commun. 2010, 391:1166-1169.
20. Li M.V., et al. Glucose-mediated transactivation of carbohydrate response element-binding protein requires cooperative actions from Mondo conserved regions and essential trans-acting factor 14-3-3. Mol. Endocrinol. 2008, 22:1658-1672.
21. Davies M.N., et al. Glucose activates ChREBP by increasing its rate of nuclear entry and relieving repression of its transcriptional activity. J. Biol. Chem. 2008, 283:24029-24038.
22. Davies M.N., et al. Activation and repression of glucose-stimulated ChREBP requires the concerted action of multiple domains within the MondoA conserved region. Am. J. Physiol. Endocrinol. Metab. 2010, 299:E665-E674.
23. Herman M.A., et al. A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism. Nature 2012, 484:333-338.
24. Dentin R., et al. Hidden variant of ChREBP in fat links lipogenesis to insulin sensitivity. Cell Metab. 2012, 15:795-797.
25. Ge Q., et al. Structural characterization of a unique interface between carbohydrate response element binding protein (ChREBP) and 14-3-3beta. J. Biol. Chem. 2012, 287:41914-41921.
26. Havula E., Hietakangas V. Glucose sensing by ChREBP/MondoA-Mlx transcription factors. Semin. Cell Dev. Biol. 2012, 23:640-647.
27. Kawaguchi T., et al. Glucose and cAMP regulate the L-type pyruvate kinase gene by phosphorylation dephosphorylation of the ChREBP. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:13710-13715.
28. Tsatsos N., et al. Identification and function of phosphorylation in the glucose-regulated transcription factor ChREBP. Biochem. J. 2008, 411:261-270.
29. Sakiyama H., et al. Regulation of nuclear import/export of carbohydrate response element-binding protein (ChREBP): interaction of an alpha-helix of ChREBP with the 14-3-3 proteins and regulation by phosphorylation. J. Biol. Chem. 2008, 283:24899-24908.
30. Kabashima T., et al. Xylulose 5-phosphate mediates glucose-induced lipogenesis by xylulose 5-phosphate-activated protein phosphatase in rat liver. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:5107-5112.
31. Ma L., et al. A critical role for the loop region of the basic helix-loop-helix/leucine zipper protein Mlx in DNA binding and glucose-regulated transcription. Nucleic Acids Res. 2007, 35:35-44.
32. Arden C., et al. Fructose 2,6-bisphosphate is essential for glucose-regulated gene transcription of glucose-6-phosphatase and other ChREBP target genes in hepatocytes. Biochem. J. 2012, 443:111-123.
33. Li M.V., et al. Glucose-6-phosphate mediates activation of the ChREBP. Biochem. Biophys. Res. Commun. 2010, 395:395-400.
34. Guinez C., et al. O-GlcNAcylation increases ChREBP protein content and transcriptional activity in the liver. Diabetes 2011, 60:1399-1413.
35. Ido-Kitamura Y., et al. Hepatic FoxO1 integrates glucose utilization and lipid synthesis through regulation of ChREBP O-glycosylation. PLoS ONE 2012, 7:e47231.
36. Tsatsos N.G., et al. Glucose activation of ChREBP in hepatocytes occurs via a two-step mechanism. Biochem. Biophys. Res. Commun. 2006, 340:449-456.
37. Collier J.J., et al. c-Myc and ChREBP regulate glucose-mediated expression of the L-type pyruvate kinase gene in INS-1-derived 832/13 cells. Am. J. Physiol. Endocrinol. Metab. 2007, 293:E48-E56.
38. Bricambert J., et al. Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice. J. Clin. Invest. 2010, 120:4316-4331.
39. Kuo M., et al. O-glycosylation of FoxO1 increases its transcriptional activity towards the glucose 6-phosphatase gene. FEBS Lett. 2008, 582:829-834.
40. Dentin R., et al. Hepatic glucose sensing via the CREB coactivator CRTC2. Science 2008, 319:1402-1405.
41. Hanover J.A., et al. Bittersweet memories: linking metabolism to epigenetics through O-GlcNAcylation. Nat. Rev. Mol. Cell Biol. 2012, 13:312-321.
42. Zhang W., et al. FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression. J. Biol. Chem. 2006, 281:10105-10117.
43. Dentin R., et al. Glucose 6-phosphate, rather than xylulose 5-phosphate, is required for the activation of ChREBP in response to glucose in the liver. J. Hepatol. 2012, 56:199-209.
44. Wu C., et al. Enhancing hepatic glycolysis reduces obesity: differential effects on lipogenesis depend on site of glycolytic modulation. Cell Metab. 2005, 2:131-140.
45. Hedeskov C.J., Capito K. The pentose cycle and insulin release in isolated mouse pancreatic islets during starvation. Biochem. J. 1975, 152:571-576.
46. Aiston S., et al. Glucose 6-phosphate regulates hepatic glycogenolysis through inactivation of phosphorylase. Diabetes 2003, 52:1333-1339.
47. McFerrin L.G., Atchley W.R. A novel N-terminal domain may dictate the glucose response of Mondo proteins. PLoS ONE 2012, 7:e34803.
48. Petrie J.L., et al. Glucose induces protein targeting to glycogen in hepatocytes by fructose 2,6-bisphosphate mediated recruitment of MondoA to the promoter. Mol. Cell. Biol. 2013, 33:725-738.
49. Van Schaftingen E. Glycolysis revisited. Diabetologia 1993, 36:581-588.
50. Iizuka K., et al. Deficiency of carbohydrate-activated transcription factor ChREBP prevents obesity and improves plasma glucose control in leptin-deficient (ob/ob) mice. Am. J. Physiol. Endocrinol. Metab. 2006, 291:E358-E364.
51. Dentin R., et al. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice. Diabetes 2006, 55:2159-2170.
52. Iizuka K., et al. Hepatic overexpression of dominant negative Mlx improves metabolic profile in diabetes-prone C57BL/6J mice. Biochem. Biophys. Res. Commun. 2009, 379:499-504.
53. Benhamed F., et al. The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans. J. Clin. Invest. 2012, 122:2176-2194.
54. Hodson L., Fielding B.A. Stearoyl-CoA desaturase: rogue or innocent bystander?. Prog. Lipid Res. 2012, 52:15-42.
55. Lodhi I.J., et al. Lipoexpediency: de novo lipogenesis as a metabolic signal transmitter. Trends Endocrinol. Metab. 2011, 22:1-8.
56. Sun Z., Lazar M.A. Dissociating fatty liver and diabetes. Trends Endocrinol. Metab. 2013, 24:4-12.
57. Sun Z., et al. Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration. Nat. Med. 2012, 18:934-942.
58. McGarry J.D., et al. The role of malonyl-CoA in the coordination of fatty acid synthesis and oxidation in isolated rat hepatocytes. J. Biol. Chem. 1978, 253:8294-8300.
59. Monsenego J., et al. Enhancing liver mitochondrial fatty acid oxidation capacity in obese mice improves insulin sensitivity independently of hepatic steatosis. J. Hepatol. 2012, 56:632-639.
60. Kursawe R., et al. Decreased transcription of ChREBP-alpha/beta isoforms in abdominal subcutaneous adipose tissue of obese adolescents with prediabetes or early type 2 diabetes: associations with insulin resistance and hyperglycemia. Diabetes 2013, 62:837-844.
61. Iizuka K., et al. Glucose induces FGF-21 mRNA expression through ChREBP activation in rat hepatocytes. FEBS Lett. 2009, 583:2882-2886.
62. Adams A.C., Kharitonenkov A. FGF21: The center of a transcriptional nexus in metabolic regulation. Curr. Diabetes Rev. 2012, 8:285-293.
63. Gao N., et al. Foxa1 and Foxa2 maintain the metabolic and secretory features of the mature beta-cell. Mol. Endocrinol. 2010, 24:1594-1604.
64. Soggia A., et al. Activation of the transcription factor ChREBP by glucose leads to increased pancreatic β-cell differentiation in rats. Diabetologia 2012, 55:2713-2722.
65. Gradwohl G., et al. Neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:1607-1611.
66. + cells are islet progenitors and are distinct from duct progenitors. Development 2002, 129:2447-2457.
67. Guillemain G., et al. Glucose is necessary for embryonic pancreatic endocrine cell differentiation. J. Biol. Chem. 2007, 282:15228-15337.
68. Poungvarin N., et al. Carbohydrate response element-binding protein (ChREBP) plays a pivotal role in β-cell glucotoxicity. Diabetologia 2012, 55:1783-1796.
69. 2+ ions in pancreatic beta-cells. Diabetes 2012, 61:574-585.
70. Henquin J.C., Rahier J. Pancreatic alpha cell mass in European subjects with type 2 diabetes. Diabetologia 2011, 54:1720-1725.
71. Butler A.E., et al. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003, 52:102-110.
72. Chen J., et al. Thioredoxin-interacting protein: a critical link between glucose toxicity and beta-cell apoptosis. Diabetes 2008, 57:938-944.
73. Chen J., et al. Thioredoxin-interacting protein deficiency induces Akt/Bcl-xL signaling and pancreatic beta-cell mass and protects against diabetes. FASEB J. 2008, 22:3581-3594.
74. Reich E., et al. Involvement of thioredoxin-interacting protein (TXNIP) in glucocorticoid-mediated beta cell death. Diabetologia 2012, 55:1048-1057.
75. Oslowski C.M., et al. Thioredoxin-interacting protein mediates ER stress-induced beta cell death through initiation of the inflammasome. Cell Metab. 2012, 16:265-273.
76. Liu J.H., et al. Possible role for the thioredoxin system in the protective effects of probucol in the pancreatic islets of diabetic rats. Clin. Exp. Pharmacol. Physiol. 2011, 38:528-533.
77. Cha-Molstad H., et al. Glucose-stimulated expression of thioredoxin-interacting protein is mediated by ChREBP, p300 and histone H4 acetylation in pancreatic β-cells. J. Biol. Chem. 2009, 284:16898-16905.
78. Dreyer C., et al. Positive regulation of the peroxisomal beta-oxidation pathway by fatty acids through activation of peroxisome proliferator-activated receptors (PPAR). Biol. Cell 1993, 77:67-76.
79. Leone T.C., et al. A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:7473-7478.
80. Sun Y., et al. Peroxisome proliferator-activated receptor-alpha regulates the expression of pancreatic/duodenal homeobox-1 in rat insulinoma (INS-1) cells and ameliorates glucose-induced insulin secretion impaired by palmitate. Endocrinology 2008, 149:662-671.
81. Boergesen M., et al. ChREBP mediates glucose repression of peroxisome proliferator-activated receptor alpha expression in pancreatic beta-cells. J. Biol. Chem. 2011, 286:13214-13225.
82. Noordeen N.A., et al. Carbohydrate-responsive element-binding protein (ChREBP) is a negative regulator of ARNT/HIF-1beta gene expression in pancreatic islet beta-cells. Diabetes 2010, 59:153-160.
83. Rogers G.J., et al. E-cadherin and cell adhesion: a role in architecture and function in the pancreatic islet. Cell. Physiol. Biochem. 2007, 20:987-994.
84. Benninger R.K., et al. Gap junctions and other mechanisms of cell-cell communication regulate basal insulin secretion in the pancreatic islet. J. Physiol. 2011, 589:5453-5466.
85. da Silva Xavier G., et al. ChREBP regulates Pdx-1 and other glucose-sensitive genes in pancreatic β-cells. Biochem. Biophys. Res. Commun. 2010, 402:252-257.
86. Gunton J.E., et al. Loss of ARNT/HIF1beta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes. Cell 2005, 122:337-349.
87. Tong X., et al. The glucose-responsive transcription factor ChREBP contributes to glucose-dependent anabolic synthesis and cell proliferation. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:21660-21665.
88. Metukuri M., et al. ChREBP mediates glucose-stimulated pancreatic β-cell proliferation. Diabetes 2012, 61:2004-2015.
89. Zhang P., et al. c-Myc is required for the ChREBP-dependent activation of glucose-responsive genes. Mol. Endocrinol. 2010, 24:1274-1286.
90. Jeong Y.S., et al. Integrated expression profiling and genome-wide analysis of ChREBP targets reveals the dual role for ChREBP in glucose-regulated gene expression. PLoS ONE 2011, 6:e22544.
91. Perilhou A., et al. The transcription factor COUP-TFII is negatively regulated by insulin and glucose via Foxo1- and ChREBP-controlled pathways. Mol. Cell. Biol. 2008, 28:6568-6579.
92. Noriega L.G., et al. CREB and ChREBP oppositely regulate SIRT1 expression in response to energy availability. EMBO Rep. 2011, 12:1069-1076.
93. Wang R.H., et al. Liver steatosis and increased ChREBP expression in mice carrying a liver specific SIRT1 null mutation under a normal feeding condition. Int. J. Biol. Sci. 2010, 6:682-690.
94. Burnett C., et al. Absence of effects of Sir2 overexpression on lifespan in C. elegans and Drosophila. Nature 2011, 477:482-485.
95. Sassu E.D., et al. Mio/dChREBP coordinately increases fat mass by regulating lipid synthesis and feeding behavior in Drosophila. Biochem. Biophys. Res. Commun. 2012, 426:43-48.
96. Poupeau A., Postic C. Cross-regulation of hepatic glucose metabolism via ChREBP and nuclear receptors. Biochim. Biophys. Acta 2011, 1812:995-1006.
97. Cao H., et al. Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell 2008, 134:933-944.